BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 16451073)

  • 1. Synthesis and structure-activity relationships of 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine analogues as potent, noncompetitive metabotropic glutamate receptor subtype 5 antagonists; search for cocaine medications.
    Iso Y; Grajkowska E; Wroblewski JT; Davis J; Goeders NE; Johnson KM; Sanker S; Roth BL; Tueckmantel W; Kozikowski AP
    J Med Chem; 2006 Feb; 49(3):1080-100. PubMed ID: 16451073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel mGluR5 antagonist, MFZ 10-7, inhibits cocaine-taking and cocaine-seeking behavior in rats.
    Keck TM; Zou MF; Bi GH; Zhang HY; Wang XF; Yang HJ; Srivastava R; Gardner EL; Xi ZX; Newman AH
    Addict Biol; 2014 Mar; 19(2):195-209. PubMed ID: 24001208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors.
    Lea PM; Movsesyan VA; Faden AI
    Br J Pharmacol; 2005 Jun; 145(4):527-34. PubMed ID: 15821750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mGluR5 antagonist-induced psychoactive properties: MTEP drug discrimination, a pharmacologically selective non-NMDA effect with apparent lack of reinforcing properties.
    Swedberg MD; Ellgren M; Raboisson P
    J Pharmacol Exp Ther; 2014 Apr; 349(1):155-64. PubMed ID: 24472725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabotropic glutamate receptor 5 (mGluR5) antagonists attenuate cocaine priming- and cue-induced reinstatement of cocaine seeking.
    Kumaresan V; Yuan M; Yee J; Famous KR; Anderson SM; Schmidt HD; Pierce RC
    Behav Brain Res; 2009 Sep; 202(2):238-44. PubMed ID: 19463707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3H]Methoxymethyl-3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine binding to metabotropic glutamate receptor subtype 5 in rodent brain: in vitro and in vivo characterization.
    Anderson JJ; Rao SP; Rowe B; Giracello DR; Holtz G; Chapman DF; Tehrani L; Bradbury MJ; Cosford ND; Varney MA
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1044-51. PubMed ID: 12438526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles.
    Varty GB; Grilli M; Forlani A; Fredduzzi S; Grzelak ME; Guthrie DH; Hodgson RA; Lu SX; Nicolussi E; Pond AJ; Parker EM; Hunter JC; Higgins GA; Reggiani A; Bertorelli R
    Psychopharmacology (Berl); 2005 Apr; 179(1):207-17. PubMed ID: 15682298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabotropic glutamate receptor subtype 5 antagonists MPEP and MTEP.
    Lea PM; Faden AI
    CNS Drug Rev; 2006; 12(2):149-66. PubMed ID: 16958988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral and functional evidence of metabotropic glutamate receptor 2/3 and metabotropic glutamate receptor 5 dysregulation in cocaine-escalated rats: factor in the transition to dependence.
    Hao Y; Martin-Fardon R; Weiss F
    Biol Psychiatry; 2010 Aug; 68(3):240-8. PubMed ID: 20416862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AZD9272 and AZD2066: selective and highly central nervous system penetrant mGluR5 antagonists characterized by their discriminative effects.
    Swedberg MD; Raboisson P
    J Pharmacol Exp Ther; 2014 Aug; 350(2):212-22. PubMed ID: 24876235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation of the effects of MTEP [3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]piperidine] on conditioned reinstatement and reinforcement: comparison between cocaine and a conventional reinforcer.
    Martin-Fardon R; Baptista MA; Dayas CV; Weiss F
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1084-90. PubMed ID: 19258516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationships comparing N-(6-methylpyridin-yl)-substituted aryl amides to 2-methyl-6-(substituted-arylethynyl)pyridines or 2-methyl-4-(substituted-arylethynyl)thiazoles as novel metabotropic glutamate receptor subtype 5 antagonists.
    Kulkarni SS; Zou MF; Cao J; Deschamps JR; Rodriguez AL; Conn PJ; Newman AH
    J Med Chem; 2009 Jun; 52(11):3563-75. PubMed ID: 19445453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The behavioral profile of the potent and selective mGlu5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in rodent models of anxiety.
    Busse CS; Brodkin J; Tattersall D; Anderson JJ; Warren N; Tehrani L; Bristow LJ; Varney MA; Cosford ND
    Neuropsychopharmacology; 2004 Nov; 29(11):1971-9. PubMed ID: 15305166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of group I metabotropic glutamate receptor antagonists on the behavioral sensitization to motor effects of cocaine in rats.
    Dravolina OA; Danysz W; Bespalov AY
    Psychopharmacology (Berl); 2006 Sep; 187(4):397-404. PubMed ID: 16896963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative Allosteric Modulators of Metabotropic Glutamate Receptors Subtype 5 in Addiction: a Therapeutic Window.
    Mihov Y; Hasler G
    Int J Neuropsychopharmacol; 2016 Jul; 19(7):. PubMed ID: 26802568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A close structural analog of 2-methyl-6-(phenylethynyl)-pyridine acts as a neutral allosteric site ligand on metabotropic glutamate receptor subtype 5 and blocks the effects of multiple allosteric modulators.
    Rodriguez AL; Nong Y; Sekaran NK; Alagille D; Tamagnan GD; Conn PJ
    Mol Pharmacol; 2005 Dec; 68(6):1793-802. PubMed ID: 16155210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of behavioral effects of cocaine by the Metabotropic Glutamate Receptor 5 Antagonist 2-Methyl-6-(phenylethynyl)-pyridine in squirrel monkeys: comparison with dizocilpine.
    Lee B; Platt DM; Rowlett JK; Adewale AS; Spealman RD
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1232-40. PubMed ID: 15550570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physical and crystallographic characterisation of the mGlu5 antagonist MTEP and its monohydrochloride.
    McIldowie MJ; Gandy MN; Skelton BW; Brotchie JM; Koutsantonis GA; Spackman MA; Piggott MJ
    J Pharm Sci; 2010 Jan; 99(1):234-45. PubMed ID: 19499574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive allosteric modulation of mGluR5 receptors facilitates extinction of a cocaine contextual memory.
    Gass JT; Olive MF
    Biol Psychiatry; 2009 Apr; 65(8):717-20. PubMed ID: 19100966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and preliminary biological evaluation of 3-[(18)F]fluoro-5-(2-pyridinylethynyl)benzonitrile as a PET radiotracer for imaging metabotropic glutamate receptor subtype 5.
    Wang JQ; Tueckmantel W; Zhu A; Pellegrino D; Brownell AL
    Synapse; 2007 Dec; 61(12):951-61. PubMed ID: 17787003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.